Rabbit Polyclonal TPD52L2 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 3 publications. Immunogen corresponding to Recombinant Fragment Protein within Human TPD52L2 aa 150 to C-terminus.
View Alternative Names
Tumor protein D54, hD54, Tumor protein D52-like 2, TPD52L2
- IP
Supplier Data
Immunoprecipitation - Anti-TPD52L2 antibody (AB194938)
Detection of Human TPD52L2 by Western Blot of Immunoprecipitates.
Lane 1 : Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from 293T cells prepared using NETN lysis buffer. Antibodies : ab194938 used for IP at 6 μg per reaction. For blotting ab194938 was used at 1 μg/ml.
Lane 2 : Control IgG.
Detection : Chemiluminescence with an exposure time of 3 minutes.
All lanes:
Immunoprecipitation - Anti-TPD52L2 antibody (ab194938)
Predicted band size: 22 kDa
false
- WB
Supplier Data
Western blot - Anti-TPD52L2 antibody (AB194938)
All lanes:
Western blot - Anti-TPD52L2 antibody (ab194938) at 0.4 µg/mL
Lane 1:
HeLa whole cell lysate at 50 µg
Lane 2:
293T whole cell lysate at 50 µg
Lane 3:
Jurkat whole cell lysate at 50 µg
Predicted band size: 22 kDa
true
Exposure time: 3min
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TPD52L2 contributes to processes such as cell proliferation and survival. It is associated with the regulation of exocytosis because of its presence in vesicles. TPD52L2 forms part of a broader protein family with conserved coiled-coil domains suggesting a capacity for protein-protein interactions. This family can affect the organization and dynamics of the cytoskeleton which is important for cytokinesis and endocytosis.
Pathways
TPD52L2 interacts directly with cellular communication and transport pathways. It is known to participate in the tumorigenesis pathway by modulating cell growth and apoptosis. The protein has interactions with key components such as PKB/AKT an important player in signaling cascades that regulate cell survival and metabolism. As a part of these pathways TPD52L2 may contribute to oncogenic transformation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Cancer & metabolism 7:1 PubMed30697423
2019
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 15:473-478 PubMed29375699
2018
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 9:3336-3344 PubMed28804551
2017
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com